SCOPUS 정보 검색 플랫폼

International Journal of Antimicrobial Agents

Volumn 31, Issue 4, 2008, Pages 395-396

Post-antibiotic effects of linezolid and other agents against Mycobacterium tuberculosis

(6) Hui, M a Au Yeang, C a Wong, K T a Chan, C Y a Yew, W W b Leung, C C c

a CHINESE UNIVERSITY OF HONG KONG (Hong Kong)

b GRANTHAM HOSPITAL (Hong Kong)

c DEPARTMENT OF HEALTH (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CAPREOMYCIN; GATIFLOXACIN; ISONIAZID; LINEZOLID; MOXIFLOXACIN; OFLOXACIN; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANTIBACTERIAL ACTIVITY; ANTITUBERCULOUS ACTIVITY; BROTH DILUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; INCUBATION TIME; INOCULATION; LETTER; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ACETAMIDES; ANTITUBERCULAR AGENTS; DRUG COMBINATIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; OXAZOLIDINONES; RIFAMPIN;

EID: 40849112990 PISSN: 09248579 EISSN: None Source Type: Journal
DOI: 10.1016/j.ijantimicag.2007.12.002 Document Type: Letter

Times cited : (10)

References (6)

1
- 0037227983
- In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs
- Alcalá L., Ruiz-Serrano M.J., Pérez-Fernández Turégano C., García De Viedma D., Díaz-Infantes M., Marín-Arriaza M., et al. In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs. Antimicrob Agents Chemother 47 (2003) 416-417
- (2003) Antimicrob Agents Chemother , vol.47 , pp. 416-417
- Alcalá, L.¹ Ruiz-Serrano, M.J.² Pérez-Fernández Turégano, C.³ García De Viedma, D.⁴ Díaz-Infantes, M.⁵ Marín-Arriaza, M.⁶

2
- 0037383008
- Synergic activity of fluoroquinolones and linezolid against Mycobacterium tuberculosis
- Rodriguez J.C., Ruiz M., Lopez M., and Royo G. Synergic activity of fluoroquinolones and linezolid against Mycobacterium tuberculosis. Int J Antimicrob Agents 21 (2003) 354-356
- (2003) Int J Antimicrob Agents , vol.21 , pp. 354-356
- Rodriguez, J.C.¹ Ruiz, M.² Lopez, M.³ Royo, G.⁴

3
- 0035191461
- Postantibiotic effects of antituberculosis agents alone and in combination
- Chan C.Y., Au-Yeang C., Yew W.W., Hui M., and Cheng A.F. Postantibiotic effects of antituberculosis agents alone and in combination. Antimicrob Agents Chemother 45 (2001) 3631-3634
- (2001) Antimicrob Agents Chemother , vol.45 , pp. 3631-3634
- Chan, C.Y.¹ Au-Yeang, C.² Yew, W.W.³ Hui, M.⁴ Cheng, A.F.⁵

4
- 0346731290
- In vitro postantibiotic effects of rifapentine, isoniazid, and moxifloxacin against Mycobacterium tuberculosis
- Chan C.Y., Au-Yeang C., Yew W.W., Leung C.C., and Cheng A.F. In vitro postantibiotic effects of rifapentine, isoniazid, and moxifloxacin against Mycobacterium tuberculosis. Antimicrob Agents Chemother 48 (2004) 340-343
- (2004) Antimicrob Agents Chemother , vol.48 , pp. 340-343
- Chan, C.Y.¹ Au-Yeang, C.² Yew, W.W.³ Leung, C.C.⁴ Cheng, A.F.⁵

5
- 0028018990
- In-vitro activity of quinolones and macrolides against mycobacteria
- Yew W.W., Piddock L.J., Li M.S., Lyon D., Chan C.Y., and Cheng A.F. In-vitro activity of quinolones and macrolides against mycobacteria. J Antimicrob Chemother 34 (1994) 343-351
- (1994) J Antimicrob Chemother , vol.34 , pp. 343-351
- Yew, W.W.¹ Piddock, L.J.² Li, M.S.³ Lyon, D.⁴ Chan, C.Y.⁵ Cheng, A.F.⁶

6
- 0242320209
- Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial
- Stalker D.J., and Jungbluth G.L. Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial. Clin Pharmacokinet 42 (2003) 1129-1140
- (2003) Clin Pharmacokinet , vol.42 , pp. 1129-1140
- Stalker, D.J.¹ Jungbluth, G.L.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.